Revolution Medicines, Inc.

Historical 13F Holders

Symbol
RVMD
CUSIP
76155X100
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 76155X100 since 12/18/2024, largest first.

Filer % of Class Filed
Farallon Capital Partners, L.P. 13G/A
7.5% 2/9/2026
Event 12/31/2025
Farallon Capital Management, L.L.C. 13G/A
6.4% 8/13/2026
Event 6/30/2026
BlackRock, Inc. 13G 5.7% 7/29/2026
Event 6/30/2026
Baker Bros. Advisors LP 13G
5.3% 8/14/2026
Event 6/30/2026
Janus Henderson Group Ltd. 13G 5.1% 8/13/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
FMR LLC 13G
5.0%
Checked 5% or less
11/5/2025
Event 9/30/2025
Wellington Management Group LLP 13G/A
3.6% 2/10/2026
Event 12/31/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 22 58.7 k $11.3 M
2026 Q2 739 259 M $40.4 B
2026 Q1 563 199 M $19.1 B
2025 Q4 410 201 M $16.0 B
2025 Q3 344 194 M $9.07 B
2025 Q2 329 191 M $7.04 B
2025 Q1 299 193 M $6.84 B
2024 Q4 301 193 M $8.45 B
2024 Q3 269 175 M $7.94 B
2024 Q2 236 174 M $6.74 B
2024 Q1 229 166 M $5.35 B
2023 Q4 208 167 M $4.79 B
2023 Q3 190 112 M $3.11 B
2023 Q2 147 112 M $2.99 B
2023 Q1 157 108 M $2.34 B
2022 Q4 143 92.0 M $2.19 B
2022 Q3 149 88.4 M $1.74 B
2022 Q2 137 76.5 M $1.49 B
2022 Q1 131 74.0 M $1.89 B
2021 Q4 125 73.4 M $1.85 B
2021 Q3 121 72.3 M $1.99 B
2021 Q2 136 70.4 M $2.23 B
2021 Q1 135 66.5 M $3.05 B
2020 Q4 123 57.4 M $2.27 B
2020 Q3 92 57.0 M $1.98 B
2020 Q2 78 47.2 M $1.49 B
2020 Q1 75 46.9 M $1.03 B